In the wake of MD Anderson’s costly failure with IBM’s Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
Apologies to Paul Simon, but there must be 50 ways to leave your employer.
Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.
Pharma spent more than $4 billion on TV ads last year. Empowered patient communities weren’t impressed. Has DTC on TV reached its moment of reckoning?